Improving the Diagnosis of Fibrodysplasia Ossificans Progressiva - 22/04/21
Doi : 10.1016/j.jpeds.2021.02.036
Peter Kannu, MB ChB, PhD, DCH, FRACP, FRCPC 1, 2, ⁎ 
, Charles E. Levy, MD 3
, Charles E. Levy, MD 3 1 The Hospital for Sick Children and Peter Gilgan Centre for Research and Learning, Toronto, Ontario, Canada
2 University of Alberta, Toronto, Ontario, Canada
3 Center for Arts in Medicine, College of the Arts, University of Florida, Gainesville, FL
∗Reprint requests: Peter Kannu, MB ChB, PhD, DCH, FRACP, FRCPC, Medical Genetics, 8-39 Medical Sciences Building, 8613-114 Street, Edmonton Alberta, T6G 2H7 Canada.Medical Genetics, 8-39 Medical Sciences Building, 8613-114 StreetEdmontonAlbertaT6G 2H7Canada
Abbreviations : ACVR1, ALK2, BMP, CT, FOP, MRI
Plan
| This article is published as part of a supplement supported by an educational grant from Ipsen Biopharmaceuticals, Inc. |
|
| Please see the author disclosures at the end of this article. |
Crown Copyright © 2021
Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 232 - N° S
P. S3-S8 - mai 2021 Retour au numéro
Article précédent
- Hardened Hope: Care Advances for Fibrodysplasia Ossificans Progressiva
- Peter Kannu, Charles E. Levy
- Evolving Management of Fibrodysplasia Ossificans Progressiva
- Peter Kannu, Charles E. Levy
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?